Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-096026
Filing Date
2019-04-03
Accepted
2019-04-03 06:06:05
Documents
10
Period of Report
2019-05-15
Effectiveness Date
2019-04-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A d721360ddef14a.htm DEF 14A 1406174
2 GRAPHIC g721360g00e27.jpg GRAPHIC 1818
3 GRAPHIC g721360g02h63.jpg GRAPHIC 1784
4 GRAPHIC g721360g13d57.jpg GRAPHIC 15542
5 GRAPHIC g721360g26n68.jpg GRAPHIC 49523
6 GRAPHIC g721360g70l14.jpg GRAPHIC 27430
7 GRAPHIC g721360g91v63.jpg GRAPHIC 1825
8 GRAPHIC g721360g98u41.jpg GRAPHIC 28250
9 GRAPHIC g721360page001.jpg GRAPHIC 155604
10 GRAPHIC g721360page002.jpg GRAPHIC 172789
  Complete submission text file 0001193125-19-096026.txt   2034259
Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1228
Type: DEF 14A | Act: 34 | File No.: 001-35803 | Film No.: 19727434
SIC: 2834 Pharmaceutical Preparations